BAX Stock Analysis: Buy, Sell, or Hold?
BAX - Baxter International Inc.
$21.32
-0.70 (-3.18%)
▼
5d:
+6.07%
30d:
+13.53%
90d:
+34.94%
HOLD
MODERATE Confidence
Analysis Updated: Jun 30, 2026 12:00 AM ET
Earnings: Jul 30, 2026
28d
Smart Money Distribution
None View Scanner →
Strength: 8.4/10
Get Alerted When BAX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: BAX trades at premium valuation expecting 5.7% growth. Hold existing positions but don't chase. Wait for better entry.
📊 HOLD: BAX trades at premium valuation expecting 5.7% growth. Hold existing positions but don't chase. Wait for better entry.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$22.58
Based on 4.5% avg growth
INTRINSIC VALUE TODAY
$14.02
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 9.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: BAX is currently trading at $21.32, which is considered extended relative to its 30-day fair value range of $18.96 to $21.00. From a valuation perspective, the stock is trading at a premium (Forward PE: 10.6) compared to its historical average (9.0). At these levels, the market is pricing in 5.7% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, BAX is in a strong downtrend. Immediate support is located at $19.38, while resistance sits at $22.18. Short-term momentum is weak, with the stock down 3.2% recently.
Market Sentiment: BAX has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, BAX is in a strong downtrend. Immediate support is located at $19.38, while resistance sits at $22.18. Short-term momentum is weak, with the stock down 3.2% recently.
Market Sentiment: BAX has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$18.96 -
$21.00
Company Quality Score
61/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
52.4%
Protect Your Profits
Holding BAX? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.2%)
- NEUTRAL: Near Wall St target ($21.54)
- NEUTRAL: PE elevated vs history but 5.7% growth expectation is conservative given 238% recent growth
Trading Range Analysis
30-Day Trading Range
$18.96 -
$21.00
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$19.38
Resistance Level
$22.18
Current Trend
Strong Downtrend
Technical data as of
Jun 30, 2026
Fundamental Context
Forward P/E (Next Year Est.)
10.59
Wall Street Target
$21.54
(+1.0%)
Revenue Growth (YoY)
2.9%
Earnings Growth (YoY)
237.9%
Profit Margin
-9.7%
Valuation Premium vs History
+5.7% premium
PE vs Historical
10.6 vs 9.0
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+5.7%
(market-implied from PE analysis)
1-Year Target
$22.54
(+6%)
2-Year Target
$23.82
(+12%)
3-Year Target
$25.18
(+18%)
3-Yr Target (if PE normalizes)
(PE: 11→9)
PE COMPRESSION
$21.39
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 5.0%)
$50.82
(+138%)
Base:
(SPY PE: 10.6, Growth: 5.0%)
$24.71
(+16%)
Bear:
(PE: 9.0, Growth: 5.0%)
$21.00
(-2%)
Share & Embed Analysis
Last updated: June 30, 2026 11:55 PM ET
Data refreshes hourly during market hours. Next update: 12:55 AM
Data refreshes hourly during market hours. Next update: 12:55 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BAX showing a specific setup today?
Insider Activity (6 Months)
4
Buys
0
Sells
+
Net
NEUTRAL
Recent Transactions
Michael T. McCaul
BUY
2026-02-17
Ro Khanna
BUY
2026-02-17
Ro Khanna
BUY
2026-01-29
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$565 | 60 HOLD |
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$88 | 58 HOLD |
|
RMD
ResMed Inc |
BUY
19 analysts |
$261 | 67 BUY |
|
RGEN
Repligen Corporation |
STRONG BUY
19 analysts |
$176 | 56 HOLD |
|
WST
West Pharmaceutical Serv… |
STRONG BUY
13 analysts |
$359 | 64 BUY |
Advanced BAX Option Strategies
Professional options setups generated by AI based on today's BAX price and gamma walls.
